A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours—a feat that's nearly unheard of in standard ...
Jan 12, 2022
0
71
Using data from smartwatches, a new algorithm reads heart rate as a proxy for physiological or mental stress, potentially alerting wearers they're falling ill before they have symptoms.
Dec 1, 2021
0
105
Activating the immune system at the site of a tumor can recruit and stimulate immune cells to destroy tumor cells. One strategy involves injecting immune-stimulating molecules directly into the tumor, but this method can ...
Nov 12, 2021
0
78
A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.
Nov 1, 2021
0
212
Researchers at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have devised a tool to examine how cells behave and interact in various environments of the body. They've used it to better understand ...
Nov 1, 2021
0
55
Stanford Medicine scientists have linked insulin resistance to an increased risk of developing major depressive disorder.
Sep 23, 2021
0
233
Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies—antibodies directed at their own tissues or at substances their immune cells secrete into the blood—than people without COVID-19, according ...
Sep 14, 2021
0
670
Can you think of what you had for breakfast? Calling up this memory will almost certainly make you think of not only where you were at the time—perhaps sitting at your kitchen table—but also what was on your mind: reviewing ...
Aug 13, 2021
1
429
Epileptic seizures trigger the rapid synthesis and release of a substance mimicked by marijuana's most psychoactive component, Stanford University School of Medicine investigators have learned. This substance is called 2-arachidonoylglycerol, ...
Aug 4, 2021
0
374
A one-two punch envisioned by many as a way to improve treatment for some blood cancers may be more challenging to implement than previously expected, according to researchers at Stanford Medicine.
Aug 4, 2021
0
195
